These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2885345)

  • 1. Early phase II clinical trial of remoxipride in treatment of schizophrenia with measurements of prolactin and neuroleptic activity.
    Chouinard G
    J Clin Psychopharmacol; 1987 Jun; 7(3):159-64. PubMed ID: 2885345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remoxipride in schizophrenia: effects on plasma prolactin.
    Chouinard G; Turnier L; Kallai-Sanfacon MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):599-603. PubMed ID: 2868493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.
    Chouinard G; Turnier L
    Psychopharmacol Bull; 1986; 22(1):267-71. PubMed ID: 2873615
    [No Abstract]   [Full Text] [Related]  

  • 4. [Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses].
    Lewander T; Westerberg SE; Ogren SO; Von Bahr C; Köhler C
    Encephale; 1990; 16(2):153-7. PubMed ID: 1972054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA; Westenberg HG
    Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL; Appelberg B; Kuoppasalmi K; Katila H; Rimón R
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
    Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
    Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
    Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
    Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
    Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
    J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term treatment of tardive dyskinesia.
    Jus A; Jus K; Fontaine P
    J Clin Psychiatry; 1979 Feb; 40(2):72-7. PubMed ID: 33156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remoxipride in schizophrenia. A preliminary report.
    den Boer JA; Verhoeven WM; Westenberg HG
    Acta Psychiatr Scand; 1986 Oct; 74(4):409-14. PubMed ID: 2880457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
    Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled clinical trial of remoxipride and chlorpromazine in newly admitted schizophrenic patients with acute exacerbation.
    Chouinard G
    Acta Psychiatr Scand Suppl; 1990; 358():111-9. PubMed ID: 1978469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
    Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
    Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.